Delivery Order SPE2DB20D1109-SPE2DB25FP24T
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,617.25 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $6,441.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.77 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on August 29, 2025, with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.18 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 250 mg tablets (60-count) on July 31, 2025, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award carries no set-aside...
- The Defense Logistics Agency awarded a $7,934.79 delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 250 mg tablets (60-count units) on May 16, 2025, with an ultimate completion date of May 19, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract executed under AmerisourceBergen Drug Corp's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) valued at $4,050.39. This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,933.54 to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta 100 mg tablets (100 count). The contract, which is a child award under a larger indefinite delivery vehicle, utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP24TDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle that extends through December 2026 and enables the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has established itself as a key supplier to Defense Health Agency and other government healthcare systems through its extensive portfolio of brand-name and generic medications across multiple therapeutic domains. This delivery order for the pain management pharmaceutical Nucynta ER exemplifies the company's ongoing role in fulfilling routine medical supply needs for military and federal healthcare operations through the DLA's global pharmaceutical prime vendor contracting structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/17/25 |